Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Thai Optical Group Public Company Limited (TOG.BK)
Nonthaburi, TH
Thai Optical Group Public Company Limited (TOG.BK), headquartered in Bang Bua Thong, Thailand, is a prominent producer and distributor of plastic optical lenses and associated products. Established in 1951, the company underwent a name change from Thai Polymer Lens Company Limited to its current title in 2004. TOG's operations are divided into two primary divisions. One segment focuses on the creation and supply of optical lenses, offering both mineral and prescription options. The other segment provides a range of additional products and services, including the sale of glass molds, reselling various goods, applying specialized hard coatings, performing anti-reflection treatments on organic lenses, and offering eyewear assembly services. The company boasts a significant international presence, exporting its goods to diverse markets across Europe, Australia, the wider Asia-Pacific region, the United States, Africa, and the Middle East, catering to both wholesale and retail clients.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.74% | +0.00% | -2.90% | +3.08% | -1.47% | +0.75% | -15.19% | -29.47% | +15.52% | -17.79% | +139.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+1.8% Q1'26: +0.3% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-18.4% Q1'26: +4.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+6.3% Q1'26: +13.4% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+10.2% Q1'26: +10.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+8.8% ★ Q1'26: +9.4% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×2.40× Q1'26: 2.24× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
2.92B
est: 2.93B (-0.2%)
|
2.99B
est: 2.99B (+0.0%)
|
3.48B
est: 3.65B (-4.9%)
|
3.54B
est: 3.75B (-5.6%)
|
4.06B
4.06B – 4.06B
+8.2% YoY
|
| EBITDA |
617.23M
est: 581.83M (+6.1%)
|
655.95M
est: 594.74M (+10.3%)
|
724.74M
est: 761.35M (-4.8%)
|
646.26M
est: 781.36M (-17.3%)
|
845.74M
845.74M – 845.74M
+8.2% YoY
|
| EBIT |
438.17M
est: 372.28M (+17.7%)
|
490.96M
est: 380.54M (+29.0%)
|
504.05M
est: 515.09M (-2.1%)
|
361.63M
est: 528.62M (-31.6%)
|
572.18M
572.18M – 572.18M
+8.2% YoY
|
| Net Income |
403.62M
est: 388.94M (+3.8%)
|
425.67M
est: 426.89M (-0.3%)
|
412.23M
est: 436.37M (-5.5%)
|
334.45M
est: 436.37M (-23.4%)
|
474.32M
474.32M – 474.32M
+8.7% YoY
|
| SGA |
295.39M
est: 299.15M (-1.3%)
|
257.95M
est: 305.79M (-15.6%)
|
319.54M
est: 354.35M (-9.8%)
|
343.00M
est: 363.66M (-5.7%)
|
393.63M
393.63M – 393.63M
+8.2% YoY
|
| EPS |
0.85
est: 0.82 (+3.7%)
|
0.90
est: 0.90 (+0.0%)
|
0.87
est: 0.92 (-5.4%)
|
0.71
est: 0.92 (-22.8%)
|
1.00
1.00 – 1.00
+8.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Torn Pracharktam | Chief Executive Officer, Member of Business Strategic Director, Acting HR Division Manager & Executive Director | 434.0K | male |
| Amolrat Pracharktam | Chief Administrative Officer, Head of Compliance Unit, Deputy CEO & Executive Director | 294.0K | female |
| Wichit Thaveeprechachat | Company Secretary & Non-Executive Director | 294.0K | female |
| Chonlada Prompanjai | Chief Accountant | — | female |
| Lindsay Jon Wynne Brown | Chief Commercial Officer | — | male |
| Michelle Hsieh | Sales Division Manager | — | female |
| Siyaporn Silprasert | Head of Investor Relations | — | female |
| Supannikar Komolboon | Chief Executive Officer of International Operations | — | female |
| Chaiwat Chittikun | Chief Operating Officer | — | male |
| Chatri Pattanalertphan | Chief Executive Officer of Accounting & Finance | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TOG.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
